Skip to content

Public FDA record

Z-1948-2026: Medtronic Sphere-9 Catheter, Model Number AFR-00001; catheter, percutaneous, cardiac ablation, for treatm

Recall record Z-1948-2026 for Medtronic, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1948-2026
Company in FDA record
Medtronic, Inc.
FDA classification date
Apr 24, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Ventricular fibrillation (VF) occurred during radiofrequency (RF) therapy with the Medtronic Sphere-9 catheter in patients who have a Biotronik Implantable Cardioverter Defibrillator (ICD) or Biotronik Cardiac Resynchronization Therapy-Defibrillator (CRT-D) implanted. The observation is caused by an interaction between the Sphere-9 catheter current flow and a safety feature built into Biotronik ICDs and CRT Ds. Medtronic recommends physicians use increased caution when using the Sphere-9 catheter for RF ablation therapy in patients implanted with a Biotronik ICD/CRT-D system, and to ensure external defibrillation systems are readily available.

Source facts

Action
Medtronic issued an URGENT: MEDICAL DEVICE CORRECTION notice to its consignees on 3/18/2026 via USPS and email. The notice explained the issue and investigations and provided procedure recommendations: Arrhythmia and or VT/ VF is a known potential adverse event during a cardiac ablation procedure, as indicated within the Sphere-9 IFU. Medtronic recommends physicians use increased caution when using the Sphere-9 catheter for RF ablation therapy in patients implanted with a Biotronik ICD/CRT-D system, and to ensure external defibrillation systems are readily available. As described in the Medtronic Sphere-9 IFU, defibrillation equipment must be available for immediate use in the case of a life-threatening arrhythmia. Further, the IFU recommends to not deliver energy when in contact with pacing and defibrillation leads. CUSTOMER ACTIONS: Follow the procedure recommendations listed in this letter in addition to the Instructions for Use (IFU) when using a Sphere-9 catheter with a concomitant Biotronik ICD/CRT-D. Complete the enclosed Customer Confirmation Form and email to RS.CFQFCA@medtronic.com. This form must be returned even if you do not have any affected product in your possession. Please forward this notice to all those who need to be aware within your organization, including, but not limited to, physicians using the Sphere-9 catheter, and maintain a copy for your records. *** Update: On 6/19/2026, Medtronic updated the field corrective action plan, including additional GTINs within scope, and a revised U.S. IFU
Initiated
2026-03-11
Root cause
Device Design
Distribution
Worldwide
Recall number
Z-1948-2026
Recall status
Open, Classified
CDRH record ID
219345
FDA classified
2026-04-24
Recall event number
98653

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗